Neurology

Complicating Cognition: Common Prostate Cancer Treatment Associated with Higher Dementia Risk

Androgen deprivation therapy (ADT) is a staple of treatment for prostate cancer, but a recent study adds to a growing body of evidence that it places men at higher risk of cognitive decline.


Alzheimer’s, Antipsychotics and Pneumonia: A Balancing Act

Recent research finds that regardless of the drug selected, physicians should exercise caution when prescribing antipsychotics to Alzheimer’s patients.


Advising Parents on Neurological Risks of Youth Football

With research yielding sometimes discordant findings regarding long-term medical risks of football, physicians are looking for answers for parents concerned about youth participation.


Rethinking the Link between Parkinson’s Disease and Circadian Rhythm Disorders

Circadian rhythm disorders, such as irregular sleep-wake rhythms, are hallmarks of Parkinson’s disease. The medical community has traditionally believed the disorders are a side effect of Parkinson’s, but a recently published study is challenging that view.


Early Arterial Stiffness Connected to Later Cognitive Decline

Arterial stiffness in people as young as their 40s can contribute to Alzheimer’s risk, data from the Framingham Heart Study show.


Stroke Treatment Uses Blood Flow to Trigger tPA Release

Researchers are developing a means to quickly dissolve blood clots using a drug-and-device combination that also reduces vascular injury.


A Way Forward in Treating Primary-Progressive Multiple Sclerosis?

The lack of a medication to treat primary-progressive multiple sclerosis (PPMS) is a source of frustration for clinicians and patients. The results of a recent phase 3 study of the drug ocrelizumab may be cause for hope.


Using Virtual Reality to Diagnose Mild Cognitive Impairment

A virtual reality game-based application is a useful tool for diagnosing mild cognitive impairment (MCI) — a condition that frequently precedes Alzheimer’s — suggests a recent study in the Journal of Alzheimer’s Disease.


Latest MS Study Combines Treatments to Increase Remission Rates

A study by the National Institute of Allergy and Infectious Diseases (NIAID) yielded extended remissions for patients coping with relapsing-remitting multiple sclerosis (RRMS).


Study Questions Value of Transcranial Direct-current Stimulation

Looking for reading material for patients curious about undergoing transcranial electrical brain stimulation to improve their mood or memory? A meta-analysis by Australian researchers may be a good place to start, at least when it comes to answering questions from patients eager to improve cognition.